Heart Center, Segeberger Kliniken GmbH (Academic Teaching Hospital of the Universities of Kiel and Hamburg), Bad Segeberg, Germany.
J Interv Cardiol. 2012 Dec;25(6):576-85. doi: 10.1111/j.1540-8183.2012.00765.x. Epub 2012 Sep 28.
To report clinical experience with longitudinal stent deformation (LSD) and observations from the bench.
LSD was recently reported with thin-strut coronary stents. Whether it is related to a particular stent or constitutes a class-effect remains debatable.
After 2 cases of LSD were reported, information was sent to operators to warn of this event and identify possible cases. All cases were reviewed to ensure LSD had occurred. Simultaneously, bench testing was conducted to identify the susceptibility of stents to longitudinal compression and whether LSD detection is influenced by fluoroscopic stent visibility.
Between July 2010 and November 2011, 2,705 coronary interventions were performed with 4,588 stents (Promus Element = 41.6%, Xience Prime = 24.4%). Six patients with LSD were identified, all with Promus Element (0.31%). Wire bias was a predisposing factor in 4 cases. All patients were treated with postdilatation and/or additional stenting. No adverse events occurred (mean 5.8 months). In bench testing, LSD occured in all examined stents, but at different levels of applied force (weight). Most shortening at 50 g was observed with Promus Element (38.9%), as was the best visibility of LSD on x-ray images. With postdilatation all stents showed some re-elongation.
In our practice LSD was a rare observation only seen with the Promus Element stent. When subjected to longitudinal compression in a bench test all contemporary stents can be compressed. Compression of Promus Element occurs at a lower force, but it is the only stent where deformations are detected with x ray. Postdilatation can partially improve LSD.
报告纵向支架变形(LSD)的临床经验和来自实验室的观察结果。
最近有报道称,薄壁冠状动脉支架出现 LSD。它是否与特定支架有关,或者是否构成一种类效应仍存在争议。
在报告了 2 例 LSD 后,将信息发送给操作人员,以警告该事件并识别可能的病例。对所有病例进行了审查,以确保 LSD 确实发生。同时,进行了实验室测试,以确定支架对纵向压缩的易感性,以及 LSD 检测是否受到荧光透视支架可见性的影响。
在 2010 年 7 月至 2011 年 11 月期间,进行了 2705 例冠状动脉介入治疗,共使用了 4588 个支架(Promus Element = 41.6%,Xience Prime = 24.4%)。发现 6 例 LSD 患者,均为 Promus Element(0.31%)。4 例患者存在导丝偏心,这是一个易感因素。所有患者均接受了后扩张和/或额外支架置入治疗。无不良事件发生(平均 5.8 个月)。在实验室测试中,所有检查的支架都出现 LSD,但施加的力(重量)不同。在 Promus Element 中观察到 LSD 最大缩短率为 38.9%,在 X 射线图像上 LSD 的可视性最佳。后扩张后,所有支架均显示出一定程度的再伸长。
在我们的实践中,LSD 是一种罕见的观察结果,仅见于 Promus Element 支架。在实验室测试中,当受到纵向压缩时,所有现代支架都可以被压缩。Promus Element 支架在较低的力下被压缩,但它是唯一可以通过 X 射线检测到变形的支架。后扩张可以部分改善 LSD。